PFIZER INC (PFE) Form 8-K — Nov 3, 2026
Pfizer's Board unanimously appointed Cecile Guegan as Chief Financial Officer and Executive Vice President, effective November 1, 2026. Guegan had served as interim CFO since August 16, 2026, so this formalizes continuity in the finance leadership role. Guegan brings over 25 years of pharmaceutical finance experience, having joined Pfizer through the 2009 Wyeth acquisition and most recently serving as SVP of Finance for the Global Biopharmaceuticals business. Her compensation includes a $1.3 million base salary and a $1.3 million target cash incentive.
Key figures
- Cfo base salary usd
- 1300000
- Appointment effective date
- 2026-11-01
- Cfo target cash incentive usd
- 1300000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.